Pre-Exposure Prophylaxis to Prevent HIV Transmission

This resource is outdated and no longer available for download. It is presented here for archival purposes only.

Although the HIV prevention medication known as PrEP, or pre-exposure prophylaxis, has been approved by the FDA for use in MSM for almost two years, many providers do not feel prepared or comfortable prescribing PrEP to their patients. In this webinar, Dr. Ken Mayer, Medical Director of The Fenway Institute, Fenway Heath, will update participants on what is currently known about PrEP implementation in real world settings, and what the barriers and facilitators are to expanding PrEP use. Dr. Krakower will then provide cases demonstrating potential strategies related to caring for patients on PrEP.